Literature DB >> 3951704

Riboflavin-responsive lipid-storage myopathy and glutaric aciduria type II of early adult onset.

M de Visser, H R Scholte, R B Schutgens, P A Bolhuis, I E Luyt-Houwen, M H Vaandrager-Verduin, H A Veder, P L Oey.   

Abstract

A 17-year-old girl with progressive lipid-storage myopathy for 2 years had low muscle carnitine levels. There was no therapeutic response to prednisone and DL-carnitine-HCl. Chemical findings indicated glutaric aciduria type II. Riboflavin therapy and a fat-restricted, carbohydrate-enriched diet resulted in dramatic improvement. Low carnitine concentrations in plasma and muscle were observed in three asymptomatic sisters who had normal urinary excretion patterns. There was impaired mitochondrial beta-oxidation in cultured skin fibroblasts from the index patient and all three siblings.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951704     DOI: 10.1212/wnl.36.3.367

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 2.  Therapy of mitochondrial disorders.

Authors:  H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 3.  Defects of fatty acid oxidation in skeletal muscle.

Authors:  D M Turnbull; K Bartlett; N J Watmough; I M Shepherd; H S Sherratt
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

4.  Brown-Vialetto-Van Laere and Fazio Londe syndromes: defects of riboflavin transport with biochemical similarities to multiple acyl-CoA dehydrogenation defects (MADD).

Authors:  Michael J Bennett
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

5.  Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency.

Authors:  R K J Olsen; M Pourfarzam; A A M Morris; R C Dias; I Knudsen; B S Andresen; N Gregersen; S E Olpin
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  Pulmonary functions and sleep-related breathing disorders in lipid storage disease.

Authors:  Züleyha Bingöl; Hacer Durmuş Tekce; Gülseren Sağcan; Piraye Serdaroğlu; Esen Kıyan
Journal:  Sleep Breath       Date:  2018-03-01       Impact factor: 2.816

7.  Newborn Screening for Glutaric Aciduria-II: The New England Experience.

Authors:  I Sahai; C L Garganta; J Bailey; P James; H L Levy; M Martin; E Neilan; C Phornphutkul; D A Sweetser; T H Zytkovicz; R B Eaton
Journal:  JIMD Rep       Date:  2013-11-05

Review 8.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

9.  Stroke, hemiparesis and deficient mitochondrial beta-oxidation.

Authors:  L Vallée; M Fontaine; J P Nuyts; G Ricart; I Krivosic; P Divry; C Vianey-Saban; M Lhermitte; J Vamecq
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

10.  The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.

Authors:  Klaus Gempel; Haluk Topaloglu; Beril Talim; Peter Schneiderat; Benedikt G H Schoser; Volkmar H Hans; Beatrix Pálmafy; Gulsev Kale; Aysegul Tokatli; Catarina Quinzii; Michio Hirano; Ali Naini; Salvatore DiMauro; Holger Prokisch; Hanns Lochmüller; Rita Horvath
Journal:  Brain       Date:  2007-04-05       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.